Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis
Erikstrup, C.; Kallestrup, P.; Zinyama-Gutsire, R.B.L.; Gomo, E.; van Dam, G.J.; Deelder, Aé.M.; Butterworth, A.E.; Pedersen, B.Klarlund.; Ostrowski, S.R.; Gerstoft, J.; Ullum, H.
American Journal of Tropical Medicine and Hygiene 79(3): 331-337
2008
ISSN/ISBN: 0002-9637 PMID: 18784223 Document Number: 202655
We previously reported that treatment for schistosomiasis in persons infected with human immunodeficiency virus 1 (HIV-1) attenuated HIV replication as measured by plasma HIV RNA. We investigated systemic inflammation as measured by plasma levels of soluble tumour necrosis factor- alpha receptor II (sTNF-rII), interleukin-8, (IL-8), and IL-10 during schistosomiasis and HIV co-infection and after schistosomiasis treatment.
Document emailed within 1 workday
Related Documents
Kallestrup, P.; Zinyama, R.; Gomo, E.; Butterworth, A.E.; Mudenge, B.; van Dam, G.J.; Gerstoft, J.; Erikstrup, C.; Ullum, H. 2005: Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load Journal of Infectious Diseases 192(11): 1956-1961Feldmeier, H.; Nogueira-Queiroz, J.A.; Peixoto-Queiroz, M.A.; Doehring, E.; Dessaint, J.P.; de Alencar, J.E.; Dafalla, A.A.; Capron, A. 1986: Detection and quantification of circulating antigen in schistosomiasis by monoclonal antibody. II. The quantification of circulating antigens in human schistosomiasis mansoni and haematobium: relationship to intensity of infection and disease status Clinical and Experimental Immunology 65(2): 232-243
Chimbari, M.J.; Dhlomo, E.; Mwadiwa, E.; Mubila, L. 2003: Transmission of schistosomiasis in Kariba, Zimbabwe, and a cross-sectional comparison of schistosomiasis prevalences and intensities in the town with those in Siavonga in Zambia Annals of Tropical Medicine and Parasitology 97(6): 605-616
Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Tagutanazvo, O.B.; Nolte, A.G.W.; Temane, A. 2019: Experiences of women enrolled in a prevention of mother to child transmission of human immunodeficiency virus infection programme in Zimbabwe Health Sa 24: 1088
Lin, W.-C.; Lin, H.-H.; Lee, S.S.-J.; Sy, C.-L.; Wu, K.-S.; Chen, J.-K.; Tsai, H.-C.; Chen, Y.-S. 2016: Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country Journal of Microbiology Immunology and Infection 49(5): 729-736
Koyanagi, A.; Humphrey, J.H.; Ntozini, R.; Nathoo, K.; Moulton, L.H.; Iliff, P.; Mutasa, K.; Ruff, A.; Ward, B.; Chidawanyika, H.; Hargrove, J.; Mahomva, A.I.; Majo, F.; Malaba, L.C.; Mbizvo, M.T.; Mzengeza, F.; Ndhlovu, M.; Piwoz, E.; Propper, L.; Rambanepasi, P.; Ruff, A.J.; Tavengwa, N.; Zijenah, L.S.; Zunguza, C.D.; Zvandasara, P. 2011: Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy Pediatric Infectious Disease Journal 30(1): 45-51
Wanchu, A.; Sud, A.; Singh, S.; Bambery, P. 2003: Human immunodeficiency virus infection in a patient with systemic lupus erythematosus Journal of the Association of Physicians of India 51: 1102-1104
Evans, B.A.; Mccormack, S.M.; Bond, R.A.; Macrae, K.D.; Thorp, R.W. 1988: Human immunodeficiency virus infection, hepatitis B virus infection, and sexual behaviour of women attending a genitourinary medicine clinic British Medical Journal 296(6620): 473-475
Cathebras, P.; Vohito, J.A.; Tamalet, C.; Yete, M.L.; Lagarde, R.; Vohito, M.D.; Ramiara, J.P.; Mbolidi, C.D.; Nama, J.; Ngbali, J.; Siopathis, M.R. 1988: Tuberculose et infection par le virus de l'immunodéficience humaine en République Centrafricaine - Tuberculosis and infection by the human immunodeficiency virus in central African Republic Medecine Tropicale 48(4): 401-407
Dercole, C.; Cravello, L.; Sperandeo, D.; Bretelle, F.; Piechon, L.; Boubli, L.; Blanc, B. 1996: Infection par le virus de l'immunodéficience humaine chez la femme enceinte : aspects généraux - Human immunodeficiency virus infection during pregnancy : generalities la Presse Medicale (1983) 25(2): 77-80
Del Olmo, J.A.; Añón, C.; Llovet, F.; Serra, M.A.; Wassel, A.; Rodrigo, J.M. 1995: Comparative study of the prevalence of hepatitis B virus infection and human immunodeficiency virus type 1 infection in the prison population between 1985 and 1992 Gastroenterologia y Hepatologia 18(8): 405-409
Atkinson, J.H.; Jin, H.; Shi, C.; Yu, X.; Duarte, N.A.; Casey, C.Y.; Franklin, D.R.; Vigil, O.; Cysique, L.; Wolfson, T.; Riggs, P.K.; Gupta, S.; Letendre, S.; Marcotte, T.D.; Grant, I.; Wu, Z.; Heaton, R.K.; Grant, I.; Atkinson, J.H.; Ellis, R.J.; McCutchan, J. A.; Marcotte, T.D.; Marquie-Beck, J.; Sherman, M.; Ellis, R.J.; McCutchan, J.A.; Letendre, S.; Capparelli, E.; Schrier, R.; Alexander, T.; Rosario, D.; LeBlanc, S.; Heaton, R.K.; Woods, S.P.; Cherner, M.; Moore, D.J.; Dawson, M.; Jernigan, T.; Fennema-Notestine, C.; Archibald, S.L.; Hesselink, J.; Annese, J.; Taylor, M.J.; Masliah, E.; Everall, I.; Achim, C.; Richman, D.; Smith, D.M.; McCutchan, J. A.; Everall, I.; Lipton, S.; Atkinson, J.H.; von Jaeger, R.; Gamst, A.C.; Cushman, C. 2011: Psychiatric context of human immunodeficiency virus infection among former plasma donors in rural China Journal of Affective Disorders 130(3): 421-428
Valenti, W.M. 1994: AIDS: problem solving in infection control. Infection control, human immunodeficiency virus, and home health care: I. Infection risk to the patient American Journal of Infection Control 22(6): 371-372
Yamada, R.; Sasagawa, T.; Kirumbi, L.W.; Kingoro, A.; Karanja, D.K.; Kiptoo, M.; Nakitare, G.W.; Ichimura, H.; Inoue, M. 2008: Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection Journal of Medical Virology 80(5): 847-855
1991: Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection Disease Markers 9(6): 348
Moscicki, A.B.; Ellenberg, J.H.; Vermund, S.H.; Holland, C.A.; Darragh, T.; Crowley-Nowick, P.A.; Levin, L.; Wilson, C.M. 2000: Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus Archives of Pediatrics and Adolescent Medicine 154(2): 127-134
Anonymous 1988: 1988 agent summary statement for human immunodeficiency virus and report on laboratory-acquired infection with human immunodeficiency virus Morbidity and Mortality Weekly Report 37(S-4): 22
Huang, L.-f.; Tang, X.-p.; Cai, W.-p.; Chen, X.-j.; Lei, C.-l.; Li, L.-h.; Zhang, F.-c. 2010: An analysis of opportunistic infection in 762 inpatients with human immunodeficiency virus infection in Guangdong areas Zhonghua Nei Ke Za Zhi 49(8): 653-656